HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert–Eaton myasthenic syndrome
- 31 December 2004
- journal article
- research article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 159 (1-2), 230-237
- https://doi.org/10.1016/j.jneuroim.2004.10.018
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- High innate production of interleukin-10 and tumor necrosis factor-α contributes to susceptibility for non-paraneoplastic Lambert–Eaton myasthenic syndromeJournal of Neuroimmunology, 2003
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- A genetically determined high setting of TNF-α influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunityHuman Immunology, 2001
- Increased frequency of HLA class II alleles DRB1∗0301 and DQB1∗0201 in Lambert-Eaton myasthenic syndrome without associated cancerHuman Immunology, 2000
- Correlation of Thymic Pathology with HLA in Myasthenia GravisClinical Immunology, 1999
- The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseasesImmunological Reviews, 1999
- HLA gene and haplotype frequencies in Dutch blood donorsTissue Antigens, 1996
- T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.The Journal of Experimental Medicine, 1995
- Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Increased frequency of IgG heavy chain marker Glm(2) and HLA-B8 in Lambert-Eaton myasthenic syndrome with and without associated lung carcinomaHuman Immunology, 1985